Human herpesvirus 6 (HHV-6) is a betaherpesvirus that is closely related to human
cytomegalovirus. It was discovered in 1986, and HHV-6 literature has expanded considerably in the …

A series of antiviral compounds were examined for their activity against human herpesvirus
type 6 (HHV‐6), type 7 (HHV‐7) and type 8 (HHV‐8). They were selected either because …

Background: Chronic obstructive pulmonary disease (COPD) is a prevalent disease that is
frequently treated in primary care. However, data regarding the primary care management of …

Education on optimal medication use is an essential strategy to improve asthma control. The
current authors investigated whether pharmacist interventions, focused on appropriate use …

Background Upper gastrointestinal (GI) symptoms are a common reason for self-treatment
with over-the-counter (OTC) medication. However, data are scarce on the typology of GI …

BACKGROUND: Data regarding the contents of home medication cabinets (HMCs), the
management of leftover medications, and the inclination of patients toward self-initiated …

What is known and Objective: There is little evidence from well‐designed randomized controlled
trials of the impact of community pharmacist intervention on the clinical management of …

Although HHV‐6A and ‐6B are known to replicate preferably in human T‐lymphocytes, in
vitro infection of several other cell types has been described. Also, the finding that both …

Background: This observational community pharmacy‐based study aimed to investigate
headache characteristics and medication use of persons with regular headache presenting for …

CMV423 (2-chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide) is a new
antiviral agent with potent and selective in vitro activity against the β-herpesvirus human …